These results reveal the regulatory mechanisms of Ets-1 expression essential for gastric cancer progression, and suggest that pancEts-1/NONO/ERG/Ets-1 axis might be of potential values as a novel target for the treatment of gastric cancer. The gene discussed is ETS1; the disease is gastric cancer.